Frederique Menzaghi Ph.D. is VP at Cara Therapeutics, Inc. (CARA). They have made 28 open-market trades across 1 company since 2015, most recently 2024-02-01.
CIK 0001597152
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 28 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CARA | 167,247 | $890K |
Shares reported on the most recent Form 4, priced at the 2024-02-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CARA | SELL · 10b5-1 | 2023-06-23 | 2023-06-27 | $3.51 | $11K | -22.2% | -10.2% | -50.1% |
| CARA | SELL · 10b5-1 | 2023-04-04 | 2023-04-06 | $4.91 | $13K | -8.7% | -7.0% | -37.8% |
| CARA | SELL | 2023-03-03 | 2023-03-07 | $9.71 | $132K | -11.5% | -25.4% | -48.9% |
| CARA | SELL · 10b5-1 | 2022-12-21 | 2022-12-23 | $11.27 | $40K | +4.3% | +15.3% | -50.6% |
| CARA | SELL · 10b5-1 | 2022-04-01 | 2022-04-05 | $11.91 | $21K | +5.5% | -32.9% | -26.8% |
| CARA | SELL · 10b5-1 | 2022-02-25 | 2022-03-01 | $10.29 | $22K | +22.5% | +23.1% | -15.7% |
| CARA | SELL | 2021-08-30 | 2021-09-01 | $14.20 | $109K | -8.6% | -4.7% | -17.6% |
| CARA | SELL | 2021-03-05 | 2021-03-08 | $17.98 | $121K | +5.8% | +46.7% | -25.5% |
| CARA | SELL | 2021-02-25 | 2021-02-25 | $19.33 | $193K | -5.3% | +1.5% | -30.9% |
| CARA | SELL · 10b5-1 | 2020-12-30 | 2020-12-30 | $15.30 | $43K | +11.5% | +22.0% | +34.3% |
| CARA | SELL | 2020-04-21 | 2020-04-21 | $15.58 | $402K | -12.1% | -1.7% | +10.2% |
| CARA | SELL | 2019-10-25 | 2019-10-29 | $19.91 | $80K | +4.1% | +27.7% | -20.8% |
| CARA | SELL | 2019-10-18 | 2019-10-22 | $19.33 | $77K | +9.8% | +21.0% | -12.5% |
| CARA | SELL | 2019-10-11 | 2019-10-16 | $18.70 | $75K | +4.5% | +9.2% | -16.5% |
| CARA | SELL | 2019-10-04 | 2019-10-08 | $19.19 | $77K | +3.6% | +12.0% | -17.7% |
| CARA | SELL | 2019-09-03 | 2019-09-05 | $22.92 | $917K | +1.1% | -18.9% | -27.4% |
| CARA | SELL | 2019-08-01 | 2019-08-05 | $23.24 | $930K | +0.7% | +2.2% | -9.3% |
| CARA | SELL | 2019-07-17 | 2019-07-19 | $27.50 | $247K | -8.6% | -9.2% | -24.8% |
| CARA | SELL | 2019-07-01 | 2019-07-03 | $21.90 | $438K | +18.3% | +2.7% | -18.7% |
| CARA | SELL | 2019-05-29 | 2019-05-30 | $21.19 | $483K | -5.4% | +6.8% | +9.8% |
| CARA | SELL | 2019-03-13 | 2019-03-14 | $18.87 | $317K | +0.1% | +2.5% | +3.5% |
| CARA | SELL | 2019-03-12 | 2019-03-14 | $17.50 | $56K | +0.1% | +2.5% | +3.5% |
| CARA | SELL | 2019-03-12 | 2019-03-14 | $18.65 | $373K | +0.1% | +2.5% | +3.5% |
| CARA | SELL · 10b5-1 | 2019-02-28 | 2019-03-04 | $17.50 | $26K | +10.9% | +15.8% | +18.4% |
| CARA | SELL · 10b5-1 | 2019-02-25 | 2019-02-27 | $17.50 | $39K | -1.6% | +12.8% | +3.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.